Intravenous penetration of fluconazole during endophthalmitis [7]

Clinical Microbiology and Infection

Volumn 3, Issue 1, 1997, Pages 143-144

  Tod, M ^a   Lortholary, O ^a   Padoin, C ^a   Chaine, G ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE;

ADULT; ANGIOGRAPHY; CANDIDIASIS; CASE REPORT; CLINICAL FEATURE; DRUG PENETRATION; ENDOPHTHALMITIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; INTRAVITREAL DRUG ADMINISTRATION; LETTER; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VITRECTOMY; VITREOUS BODY;

EID: 0030998577     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1997.tb00269.x     Document Type: Letter

References (5)

1. Akler ME Vellend H McNeely DM Walmsley SL Gold WL Use of fluconazole in the treatment of candidal endophthalmitis Clin Infect Dis 20 1995 657 664
2. Urbak SF Degn T Fluconazole in the management of fungal ocular infections Ophthalmologica 208 1994 147 156
3. Arredondo G Martinez-Jorda R Calvo R Aguirre C Suarez E Protein binding of itraconazole and fluconazole in patients with chronic renal failure Int J Clin Pharmacol Ther 32 1994 361 364
4. Como JA Dismukes WE Oral azole drugs as systemic antifungal therapy N Engl J Med 330 1994 263 272
5. Berenguer J Ali NM Allende MC Itraconazole for experimental pulmonary aspergillosis: correlation between therapeutic response and itraconazole concentration in plasma Antimicrob Agents Chemother 38 1994 1303 1318